Dot-C
A cluster randomised feasibility trial evaluating d irectly o bserved an t i-H C V therapy in a population receiving opioid substitute therapy from community pharmacy
Bibliographic Data
| ID | 14909405 |
|---|---|
| Authors | Andrew Radley (0000-0003-4772-2388, King's Cross Hospital, corresponding author), Jan Tait (NHS Tayside), Jessica Dillon (0000-0002-2164-4476, Ninewells Hospital) |
| Year | 2017 |
| Volume | 47 |
| Pages | 126-136 |
| Publication date | 2017-09-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Drug Policy (JOURNAL) |
| Journal identifiers | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2017.05.042 |
| PMID | 28647161 |
| OpenAlex | W2716907322 |
| Language | EN |
| Citations received | 9 |
| References cited | 39 |
Family medicine · Hepatitis C · Medication therapy management · Pharmacist · Physical therapy · Population · Randomized controlled trial · Advanced Causal Inference Techniques · Hepatitis C virus research · Liver Disease Diagnosis and Treatment · Medicine · Internal Medicine · Pharmacy
What do primary care staff know and do about blood borne virus testing and care for migrant patients? A national survey
Integrating hepatitis C and addiction care for people who inject drugs in the era of direct-acting antiviral therapy
Utilising an access to care integrated framework to explore the perceptions of hepatitis C treatment of hospital-based interventions among people who use drugs
Elimination of hepatitis C virus infection among PWID
Caring and curing
Not just one box that you tick off’ – Deconstructing the hepatitis C care cascade in the interferon-free direct acting antiviral era from the client perspective
Hepatitis C care continuum and associated barriers among people who inject drugs in Chennai, India
Applying a diffusion of innovations framework to the scale-up of direct-acting antiviral therapies for hepatitis C virus infection
Barriers and facilitators to implementing a Pharmacist, Physician, and Patient Navigator-Collaborative Care Model (PPP-CCM) to treat hepatitis C among people who inject drugs
Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers
Hepatitis C treatment access and uptake for people who inject drugs
Implementation Intentions and Goal Achievement
How We Design Feasibility Studies
Normalisation process theory
Global prevalence and genotype distribution of hepatitis C virus infection in 2015
The effect of introducing point-of-care or dried blood spot analysis on the uptake of hepatitis C virus testing in high-risk populations
Community pharmacy and public health in Great Britain, 1936 to 2006
| Unique citing works | 9 |
|---|---|
| Citations per year | 1 |
| Citation span | 2017 - 2023 (7) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 9 |